Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen ...
Inogen, Inc. INGN recently announced the FDA 510(k) clearance for the SIMEOX 200 Airway Clearance Device. The clearance is ...
Jane Street Group LLC trimmed its holdings in Inogen, Inc. (NASDAQ:INGN – Free Report) by 83.1% during the third quarter, ...
Inogen ( NASDAQ:INGN ) Third Quarter 2024 Results Key Financial Results Revenue: US$88.8m (up 5.8% from 3Q 2023). Net... While the top- and bottom-line numbers for Inogen (INGN) give a sense of ...
A look at the shareholders of Inogen, Inc. ( NASDAQ:INGN) can tell us which group is most powerful. We can see that institutions own the lion's share in the company with 78% ownership. That is, the ...
StockNews.com cut shares of Inogen (NASDAQ:INGN – Free Report) from a buy rating to a hold rating in a research note published on Friday. Separately, Needham & Company LLC reaffirmed a “hold” rating ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has ...
The latest announcement is out from Inogen ( (INGN)). Don't Miss Our New Year's Offers: Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks ...
Inogen, Inc. INGN is well-poised for growth ... The renowned provider of POCs has a market capitalization of $222.5 million. The company projects 61% earnings growth for 2024 and expects to ...
The Zacks Consensus Estimate for fiscal 2024 revenues is pegged at $329.5 million, indicating 4.4% growth from the reported fiscal 2023. The SIMEOX 200 Airway Clearance Device by Inogen is an ...